Prozac and Transderm scop drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prozac (fluoxetine hydrochloride) and Transderm scop (scopolamine). Common drug interactions include speech disorder among females and therapeutic response unexpected among males.

The phase IV clinical study analyzes what interactions people have when they take Prozac and Transderm scop. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Prozac?

Prozac has active ingredients of fluoxetine hydrochloride. It is often used in depression. eHealthMe is studying from 82,988 Prozac users. Check the latest studies of Prozac.

What is Transderm scop?

Transderm scop has active ingredients of scopolamine. It is often used in motion sickness. eHealthMe is studying from 3,011 Transderm scop users. Check the latest studies of Transderm scop.



On Jul, 11, 2026

59 people who take Prozac and Transderm scop together, and have interactions are studied.

Prozac and Transderm scop drug interactions.

What are the common drug interactions of Prozac and Transderm Scop, by gender? *:

female:

  1. Speech disorder
  2. Spinal fusion surgery
  3. Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
  4. Suicidal ideation
  5. Sweating increased (excess sweating)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  7. Therapeutic response unexpected
  8. Vision blurred
  9. Wound
  10. Tremor (trembling or shaking movements in one or more parts of your body)

male:

  1. Therapeutic response unexpected
  2. Arthropathy
  3. Type 2 diabetes mellitus
  4. Abdominal pain
  5. Agitation (state of anxiety or nervous excitement)
  6. Application site erythema (redness of the skin at application site)
  7. Application site irritation
  8. Ataxia (loss of full control of bodily movements)
  9. Balance disorder
  10. Cerumen impaction

What are the common drug interactions of Prozac and Transderm Scop, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

30-39:

  1. Diplopia (double vision)
  2. Drug effect decreased

40-49:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Suicidal ideation
  3. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  4. Vision blurred
  5. Vomiting
  6. Back injury
  7. Loss of consciousness
  8. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  9. Therapeutic response unexpected
  10. Arthropathy

50-59:

  1. Dehydration (dryness resulting from the removal of water)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Chills (felling of cold)
  4. Crying
  5. Diarrhoea
  6. Incoherent (talking in a confused and unclear way)
  7. Pyrexia (fever)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Vomiting
  10. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

60+:

  1. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  2. Tremor (trembling or shaking movements in one or more parts of your body)
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Application site erythema (redness of the skin at application site)
  5. Application site irritation
  6. Application site reaction
  7. Arthropathy
  8. Balance disorder
  9. Cerumen impaction
  10. Chills (felling of cold)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 30 people, 50.85%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 25 people, 42.37%
  3. Pain: 8 people, 13.56%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 8.47%
  5. Insomnia (sleeplessness): 5 people, 8.47%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 8.47%
  7. Migraine Without Aura (headache without neurological problems): 3 people, 5.08%
  8. Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 3 people, 5.08%

* Approximation only. Some reports may have incomplete information.

Do you take Prozac and Transderm scop?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prozac and Transderm scop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prozac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Transderm scop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prozac and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Transderm scop and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride and scopolamine (the active ingredients of Prozac and Transderm scop, respectively), and Prozac and Transderm scop (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: